home>neuroanatomy>publications.html Seite teilen:

Recent Publications

Klimaschewski L.P. Parkinson's and Alzheimer's today – About neurodegeneration and its therapy. SPRINGER, 2022 (non-fiction book)

Hausott B, Glueckert R, Schrott-Fischer A, Klimaschewski L. Signal transduction regulators in axonal regeneration. CELLS, 2022 (review)

Freilinger M, Klimaschewski L, Brenner E. Innsbruck's Institute of Histology in the Third Reich: Specimens from NS-Victims. ANNALS OF ANATOMY, 2022

Klimaschewski LP. Parkinson und Alzheimer heute – Was wir über Neurodegeneration und ihre Therapie wissen. SPRINGER, 2021 (Sachbuch)

Klimaschewski L, Claus P. Fibroblast growth factor signalling in the diseased nervous system. MOLECULAR NEUROBIOLOGY, 2021 (review)

Jamsuwan S, Klimaschewski L, Hausott B. Simultaneous knockdown of Sprouty2 and PTEN promotes axon elongation of adult sensory neurons. FRONTIERS IN CELLULAR NEUROSCIENCE, 2020

Fogli B, Corthout N, Kerstens A, Bosse F, Klimaschewski L, Munck S, Schweigreiter R. Imaging of regenerating axons within nerve conduits. SCIENTIFIC REPORTS, 2019

Hausott B, Klimaschewski L. Promotion of peripheral nerve regeneration by stimulation of the ERK pathway. THE ANATOMICAL RECORD, 2019 (review)

Hausott B, Förste A, Zach F, Mangger S, Haugsten EM, Klimaschewski L. Endocytosis and transport of growth factor receptors in peripheral axon regeneration: Novel lessons from neurons expressing lysine deficient FGF receptor type 1 in vitro. THE ANATOMICAL RECORD, 2019

Hausott B, Park JW, Valovka T, Offterdinger M, Hess MW, Geley S, Klimaschewski L. Subcellular localization of Sprouty2 in human glioma cells. FRONTIERS IN MOLECULAR NEUROSCIENCE, 2019

Csanaky K, Hess MW, Klimaschewski L. Membrane-associated, not cytoplasmic or nuclear, FGFR1 induces neuronal differentiation. CELLS, 2019

Hausott B, Klimaschewski L. Sprouty2 – a novel therapeutic target in the nervous system? MOLECULAR NEUROBIOLOGY, 2018 (review)

Park JW, Wollmann G, Urbiola C, Fogli B, Florio T, Geley S, Klimaschewski L. Sprouty2 enhances the tumorigenic potential of GBM cells. NEURO-ONCOLOGY, 2018